These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15640622)
1. Opposite effects of endostatin on different endothelial cells. Schmidt A; Addicks K; Bloch W Cancer Biol Ther; 2004 Nov; 3(11):1162-6; discussion 1167-8. PubMed ID: 15640622 [TBL] [Abstract][Full Text] [Related]
2. Insights into differential endostatin activity. Maclachlan TK; Dhanabal M Cancer Biol Ther; 2004 Nov; 3(11):1167-8. PubMed ID: 15640617 [No Abstract] [Full Text] [Related]
3. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells]. Yang F; He YL Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091 [TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization. Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141 [TBL] [Abstract][Full Text] [Related]
5. Influence of endostatin on embryonic vasculo- and angiogenesis. Schmidt A; Wenzel D; Ferring I; Kazemi S; Sasaki T; Hescheler J; Timpl R; Addicks K; Fleischmann BK; Bloch W Dev Dyn; 2004 Jul; 230(3):468-80. PubMed ID: 15188432 [TBL] [Abstract][Full Text] [Related]
6. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. Delaney CE; Weagant BT; Addison CL Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139 [TBL] [Abstract][Full Text] [Related]
7. E-selectin is required for the antiangiogenic activity of endostatin. Yu Y; Moulton KS; Khan MK; Vineberg S; Boye E; Davis VM; O'Donnell PE; Bischoff J; Milstone DS Proc Natl Acad Sci U S A; 2004 May; 101(21):8005-10. PubMed ID: 15148373 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenesis effects of endostatin in retinal neovascularization. Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016 [TBL] [Abstract][Full Text] [Related]
9. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. Veillard F; Saidi A; Burden RE; Scott CJ; Gillet L; Lecaille F; Lalmanach G J Biol Chem; 2011 Oct; 286(43):37158-67. PubMed ID: 21896479 [TBL] [Abstract][Full Text] [Related]
10. Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells. Wang YS; Eichler W; Friedrichs U; Yafai Y; Hoffmann S; Yasukawa T; Hui YN; Wiedemann P Curr Eye Res; 2005 Jun; 30(6):479-89. PubMed ID: 16020281 [TBL] [Abstract][Full Text] [Related]
11. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity. Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug. Tan H; Mu G; Zhu W; Liu J; Wang F Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643 [TBL] [Abstract][Full Text] [Related]
13. The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent. Addison CL; Nör JE; Zhao H; Linn SA; Polverini PJ; Delaney CE BMC Cell Biol; 2005 Oct; 6():38. PubMed ID: 16262896 [TBL] [Abstract][Full Text] [Related]
14. Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment. Alahuhta I; Aikio M; Väyrynen O; Nurmenniemi S; Suojanen J; Teppo S; Pihlajaniemi T; Heljasvaara R; Salo T; Nyberg P Exp Cell Res; 2015 Aug; 336(1):130-40. PubMed ID: 26112215 [TBL] [Abstract][Full Text] [Related]
15. Endostatin and anastellin inhibit distinct aspects of the angiogenic process. Neskey DM; Ambesi A; Pumiglia KM; McKeown-Longo PJ J Exp Clin Cancer Res; 2008 Nov; 27(1):61. PubMed ID: 18983664 [TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states. Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497 [TBL] [Abstract][Full Text] [Related]
19. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1. Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281 [TBL] [Abstract][Full Text] [Related]
20. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling. Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]